KIF27 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.76170000388521E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.35770000000569E-05 |
Normal-vs-Stage2 |
1.699780E-03 |
Normal-vs-Stage3 |
2.6916999740223E-09 |
Normal-vs-Stage4 |
1.68549996182321E-09 |
Stage1-vs-Stage2 |
6.904400E-01 |
Stage1-vs-Stage3 |
3.581400E-04 |
Stage1-vs-Stage4 |
2.234600E-04 |
Stage2-vs-Stage3 |
8.950500E-02 |
Stage2-vs-Stage4 |
5.448200E-02 |
Stage3-vs-Stage4 |
6.587400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.03889999936158E-08 |
Normal-vs-AfricanAmerican |
8.3656000000043E-05 |
Normal-vs-Asian |
9.415000E-01 |
Caucasian-vs-AfricanAmerican |
7.915600E-01 |
Caucasian-vs-Asian |
3.250500E-02 |
AfricanAmerican-vs-Asian |
4.085900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.45960005088131E-09 |
Normal-vs-Female |
1.79787999999848E-05 |
Male-vs-Female |
6.792400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.607400E-04 |
Normal-vs-Age(41-60Yrs) |
6.23279999999449E-05 |
Normal-vs-Age(61-80Yrs) |
3.37359999935671E-08 |
Normal-vs-Age(81-100Yrs) |
3.619100E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.891200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.634200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.688400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.640400E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.049600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.991600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.897000E-01 |
Normal-vs-Grade 2 |
3.196100E-04 |
Normal-vs-Grade 3 |
4.35550000510432E-08 |
Normal-vs-Grade 4 |
1.46319623084423E-11 |
Grade 1-vs-Grade 2 |
1.296430E-01 |
Grade 1-vs-Grade 3 |
3.203500E-03 |
Grade 1-vs-Grade 4 |
2.17449999999619E-05 |
Grade 2-vs-Grade 3 |
4.135800E-03 |
Grade 2-vs-Grade 4 |
3.08720000008478E-07 |
Grade 3-vs-Grade 4 |
6.001400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.662600E-03 |
Normal-vs-ccB subtype |
6.45489994788306E-10 |
ccA subtype-vs-ccB subtype |
6.11289999999931E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.96480000000687E-07 |
Normal-vs-N1 |
1.039130E-03 |
N0-vs-N1 |
1.851380E-01 |
|
|